KabuDo

NASDAQ: SNPS · Application Software

Synopsys

Synopsys, based in Sunnyvale, California, supplies electronic design automation software, silicon IP and, since buying Ansys in July 2025, simulation and analysis software. FY2025 revenue was $7,054M, with Design Automation $5,302M and Design IP $1,752M. The Ansys deal raised debt to $13,485M. Revenue for the first nine months of FY2026 rose 49% to $7,162M. It approved cutting about 10% of its workforce in November 2025 and signed a cooperation agreement with Elliott in May 2026.

Last updated

Analysis last edited: November 6, 2026 · Financial data fetched: November 4, 2026 15:22 (SEC EDGAR) · Source 10-K filed: December 22, 2025

Built on10-K FY2025 · filed 2025-12-2210-Q (quarter ended 2026-07-31) · filed 2026-08-26Proxy statement (2026)

Next update expectedAfter FY2026’s 10-K is filed (roughly 60–90 days after fiscal year end (sooner for larger filers)), financials and analysis will be refreshed.

01

At a glanceFrom SEC data

Eight headline measures, each placed among the companies covered on this site.

Revenue growth
13.9%

Higher than 76% of 372 non-financial companies

Average yearly growth over the years shown

Operating margin
13.0%

Higher than 33% of 311 non-financial companies

Latest fiscal year (FY2025)

ROIC minus WACC
-7.8 pts

Higher than 8% of 311 non-financial companies

Return on capital above (or below) its estimated cost

Net debt ÷ EBITDA
6.7x

Higher than 95% of 304 non-financial companies

Below 0 means more cash than debt

Cash conversion
1.14x

Higher than 18% of 349 non-financial companies

Operating cash flow ÷ net income

Dividend raises
—

Years the dividend per share rose, of the last 5

P/E today
80.3x

Latest close 2026-11-04; trailing 12 months to 2026-07-31

Beta
1.36

Above 1 = moves more than the market

Each marker shows where this company sits among the non-financial companies covered on this site, not all listed companies (left = lowest, right = highest). A high position is not automatically good — for net debt ÷ EBITDA, higher means more debt. Details and formulas are in the sections below and in How to read this.

02

Valuation todayFrom SEC data

Price-based measures at the latest close, next to the same measures at the last fiscal year-end.

Share price$465.05close on 2026-11-04

Market cap$86.5B

P/E today
80.3x

At FY2025 year-end: 56.5x

Earnings: trailing 12 months to 2026-07-31

P/B today
3.1x

At FY2025 year-end: 3.0x

Book value at FY2025 year-end

EV/EBITDA today
61.6x

At FY2025 year-end: 60.3x

EBITDA for FY2025

FCF yield today
1.6%

At FY2025 year-end: 1.6%

Free cash flow for FY2025

Dividend yield today
—

Dividends per share for FY2025

“Today” uses the latest closing price (2026-11-04, Yahoo Finance daily closing prices) and shares outstanding at the last fiscal year-end. The rest of this page — including the financial table and ROIC vs. WACC — uses fiscal year-end prices. These are reference figures, not a judgment of whether the stock is cheap or expensive.

03

What changed since last earningsFrom SEC data

The latest reported quarter against the same quarter a year earlier, the balance sheet against the previous quarter-end, and what management said in its latest earnings release.

Quarter ended Jul 31, 2026.

  • Revenue↑ +42.4%$1.74B → $2.48B (vs. a year earlier)
  • Operating margin↑ +4.9 pts9.5% → 14.4% (vs. a year earlier)
  • Net income↑ +125.1%$243M → $546M (vs. a year earlier)
  • Diluted EPS↑ +89.3%$1.50 → $2.84 (vs. a year earlier)
  • Cash↑ +49.5%$2.41B → $3.61B (vs. previous quarter-end)
  • Long-term debt→ +0.0%$10.04B → $10.04B (vs. previous quarter-end)

Source: Form 10-Q ↗ (SEC XBRL). Long-term debt is the tagged long-term debt figure and leaves out short-term borrowings.

From the earnings release of Aug 26, 2026.

Management outlook ↑ Raised

Raised full-year revenue expectation to $9.715B at the midpoint. Source sentence
Raising expectations for full-year total revenue to $9.715 billion at the midpoint and full-year non-GAAP EPS guidance to $15.07 at the midpoint on continued AI-driven demand strength

Key changes

  • EPS $3.91, above the high end of prior guidance. Source sentence
    EPS of $3.91, exceeding high-end of prior guidance

Written by AI. A line appears only if its figures and direction match the quoted sentence, which an automatic check confirms. Companies' outlooks are their own and may not be met. Read the release ↗

04

Company profileFrom SEC dataShow

Legal name
SYNOPSYS INC
Headquarters
SUNNYVALE, CA
Incorporated in
Delaware
Fiscal year end
10/31
Exchange & ticker
NASDAQ: SNPS
Industry
Application Software
CIK
883241

Workforce (as of FY2025 year-end)

  • Employees

    28,000

Source: Form 10-K (FY2025) cover page and business description

05

Earnings calendarFrom SEC dataShow

When the company reports each quarter: the quarter-end date, the day results were released, and when the 10-Q or 10-K was filed.

Next report

Q4 FY2026

Quarter end: October 2026. In past years, Q4 results were released 29–40 days after quarter end (Dec 10, 2025; Dec 4, 2024; Nov 29, 2023). No date has been announced in the sources this site uses.

Reporting pattern

  • Fiscal year ends around October 31.
  • Reports four times a year: three quarterly reports (10-Q) and an annual report (10-K) for Q4.
  • Earnings releases came 21–40 days after quarter end over the last 12 quarters.
QuarterQuarter endedEarnings release (8-K)Report filed (10-Q / 10-K)
Q3 FY2026Jul 31, 2026Aug 26, 2026 (+26 days)Aug 26, 2026 10-Q (+26 days)
Q2 FY2026Apr 30, 2026May 27, 2026 (+27 days)May 27, 2026 10-Q (+27 days)
Q1 FY2026Jan 31, 2026Feb 25, 2026 (+25 days)Feb 25, 2026 10-Q (+25 days)
Q4 FY2025Oct 31, 2025Dec 10, 2025 (+40 days)Dec 22, 2025 10-K (+52 days)
Q3 FY2025Jul 31, 2025Sep 9, 2025 (+40 days)Sep 9, 2025 10-Q (+40 days)
Q2 FY2025Apr 30, 2025May 28, 2025 (+28 days)May 28, 2025 10-Q (+28 days)
Q1 FY2025Jan 31, 2025Feb 26, 2025 (+26 days)Feb 26, 2025 10-Q (+26 days)
Q4 FY2024Oct 31, 2024Dec 4, 2024 (+34 days)Dec 19, 2024 10-K (+49 days)
Q3 FY2024Jul 31, 2024Aug 21, 2024 (+21 days)Aug 23, 2024 10-Q (+23 days)
Q2 FY2024Apr 30, 2024May 22, 2024 (+22 days)May 24, 2024 10-Q (+24 days)
Q1 FY2024Jan 31, 2024Feb 21, 2024 (+21 days)Feb 23, 2024 10-Q (+23 days)
Q4 FY2023Oct 31, 2023Nov 29, 2023 (+29 days)Dec 12, 2023 10-K (+42 days)

Source: SEC EDGAR filing history. Release dates are the dates the earnings release was furnished to the SEC on Form 8-K (Item 2.02), which is normally the day results are announced. For a quarter whose 10-Q or 10-K isn’t filed yet, the date is the latest Item 2.02 8-K since the previous report, which may be a preliminary or other results-related update. Fiscal years are labeled by the calendar year in which they end.

06

Flagship products & servicesSite analysis

  • Design Automation

    EDA solutions

    Digital, custom and FPGA IC design, verification software and hardware.

  • Design Automation

    Ansys simulation and analysis

    Engineering simulation and analysis software.

  • Design IP

    Silicon IP

    Silicon-proven IP solutions for system-on-chips.

From the Form 10-K, FY2025, year ended 2025-10-31.

U.S., worldwide and country/regional share of flagship products/services

Only shares the company itself states (in its filings or press releases, sometimes citing a research firm) are shown. Scope and timing vary by figure — treat these as approximate.

  • EDA and engineering simulation software

    Engineering software

    U.S. share

    —

    Not disclosed

    Worldwide share

    Global leader

    Company-disclosed

    “Following the completion of the Ansys Merger… we are the global leader in engineering S&A software.”

Sources:

No percentage share is given.

07

Recent strategic focusSite analysis

Recent developments.

  1. Q3 FY2026 results

    Q3 revenue $2,477M (vs $1,740M); net income $546M (vs $243M).

    Source: Form 10-Q (quarter ended 2026-07-31)

  2. Restructuring

    Approved in November 2025; about 10% of the workforce.

    Source: Form 8-K (2025-11-12) — Item 2.05 restructuring

  3. Elliott

    May 2026 cooperation agreement added Jesse Cohn to the board.

    Source: Form 8-K (2026-05-27) — Item 1.01 Elliott cooperation agreement

  4. Buybacks

    $1 billion accelerated repurchase announced October 5, 2026.

    Source: Form 8-K (2026-10-05) — Item 8.01 accelerated share repurchase

Capex ÷ D&A (FY2025)

0.26x

Below depreciation — investment is being pared back

formulacapital expenditures ÷ depreciation & amortization

e.g.$169M ÷ $660M = 0.26x

termsCapital expenditures (capex) · Depreciation & amortization (D&A)

R&D-to-revenue ratio (FY2025)

35.1%

formularesearch & development expense ÷ revenue × 100

e.g.$2,479M ÷ $7,054M × 100 = 35.1%

termsResearch & development (R&D) · Revenue (net sales)

Where the money goes, over time

Unit: $M. Capex went from $155M in FY2020 to $169M in FY2025

  • Capex
  • R&D

formulacapital expenditures ÷ depreciation & amortization

termsCapital expenditures (capex) · Depreciation & amortization (D&A)

Source: each period's Form 10-K (SEC EDGAR). Latest: filed 2025-12-22

08

Key figures at a glanceFrom SEC data

FY2020–FY2025, 6 years.

Revenue (FY2025)

$7.05B

As reported in the 10-K

Revenue CAGR (5 years)

+13.9%▲favorable

formula(last-period revenue ÷ first-period revenue) ^ (1 ÷ years) − 1

e.g.($7,054M ÷ $3,685M) ^ (1÷5) − 1 = 13.9%

termsCAGR · ^ (exponent) · Revenue (net sales)

Operating margin (FY2025)

13.0%▼caution

-3.9pt vs. 5 years ago

formulaoperating income ÷ revenue × 100

e.g.$915M ÷ $7,054M × 100 = 13.0%

termsOperating income · Revenue (net sales)

ROE (FY2025)

7.1%

6-year average: 17.5%

As reported in the 10-K

P/B (FY2025 end)

2.98x

formulafiscal year-end closing price ÷ book value per share

e.g.$453.82 ÷ $152.30 = 2.98x

termsP/B · BVPS

Period-end (fiscal year-end) value, not today's P/B

EV/EBITDA (FY2025 end)

60.3x

formula(market cap + interest-bearing debt − cash and equivalents) ÷ (operating income + depreciation & amortization)

e.g.($84,408M + $13,485M − $2,888M) ÷ ($915M + $660M) = 60.3x

termsEV/EBITDA · Market capitalization · Interest-bearing debt · EBITDA · Depreciation & amortization (D&A)

Period-end (fiscal year-end) value, not today's multiple

  • ▲

    Revenue grew +13.9% a year over 5 years (strong growth)

    From $3.69B in FY2020 to $7.05B in FY2025. The annualized rate (CAGR) makes it possible to compare growth pace across companies of different sizes.

  • ▼

    Operating margin declined: 16.8% → 13.0%

    How much operating profit is left per $100 of revenue. It moved -3.9 points over 5 years — pricing power, cost control, and product mix all show up here.

  • ▲

    Equity ratio is 58.7% (a high level of financial stability)

    The share of total assets funded by equity rather than debt. 50%+ is often read as low bankruptcy risk, though the right level varies by industry (real estate and leasing run lower, for instance).

  • ▲

    Free cash flow was positive in 6 of 6 years

    Operating cash flow minus capital expenditures: the cash left over after funding the business’s own investment, available for dividends, buybacks, acquisitions, or debt paydown. A negative year can mean heavy investment, or weak core earnings — worth distinguishing.

  • ▲

    ROE averaged 17.5% over 6 years (latest: 7.1%)

    How much profit was generated on shareholders’ equity. Roughly 10%+ is often cited as solid for a U.S. company, though this varies a lot by industry and capital intensity.

09

Business modelSite analysis

Licenses design software and IP, with time-based products about half of revenue, to companies designing chips and systems, plus simulation and analysis software from Ansys.

How money and goods flow at Synopsys
  1. 01 what it draws on

    Inputs & resources

    • About 28,000 employees (23% in the U.S.) at FY2025 year-end
    • Research and development
    • Ansys simulation software
  2. 02 what it does

    Activities

    • EDA software for IC design and verification
    • Silicon-proven IP for system-on-chips
    • Simulation and analysis; design services
  3. 03 who it serves

    Customers

    • Semiconductor companies
    • Systems companies
    • Engineering users of simulation software
  4. 04 how money comes in

    How it earns

    • Revenue $7,054M (FY2025)
    • Design Automation $5,302M; Design IP $1,752M
    • Time-based products 49% of revenue

How the business makes money

  • Ansys contributed $86.5M of time-based revenue in FY2025.
  • Design IP fell 8% in FY2025.
  • No customer above 10% of receivables.

Government & regulation around the business

Non-market factors from the company’s filings: what governments and regulators fund, buy, set, approve or restrict, and which part of the flow above each one touches.

Export controls on chip design software directly affect Synopsys’s China business.

  • Trade & export rules

    Export rules on EDA

    BIS restricts ECAD software for certain ICs and adds Chinese firms to the Entity List; restrictions in Q3 2025 were later rescinded.

    Constrains the businessTouches: Customers · How it earns

    Source: Form 10-K (FY2025, year ended 2025-10-31)

Revenue by segment (FY2025)

Unit: $M — bar length = revenue, (%) = share of total company revenue

  • Design Automation

    5,302.4 (75%)
  • Design IP

    1,751.8 (25%)

Source: Form 10-K (FY2025, year ended 2025-10-31) Two reportable segments.

10

Where it earnsSite analysis

Many U.S.-listed companies earn most of their revenue outside the U.S. — this breaks down revenue by country/region so it's clear where the business actually makes its money.

Largest market (FY2025)

United States — 44% of revenue

Revenue by country / region (FY2025)

Unit: $M — bar length = revenue, (%) = share of total company revenue

  • United States

    3,100.1 (44%)
  • Korea

    947 (13%)
  • Europe

    888.5 (13%)
  • China

    814.3 (12%)
  • Other

    1,304.2 (18%)

Source: Form 10-K (FY2025, year ended 2025-10-31) China fell from $989.5M in FY2024.

11

Contract structureSite analysisShow

Short-term or spot sales carry different earnings quality than long-term or auto-renewing contracts — this shows how the company actually contracts with its customers.

12

Customers & suppliersSite analysis

Who the company sells to and buys from. Companies rarely name either, so named counterparties come only from the company's own filings and press releases; otherwise this lists the concentration figures the 10-K discloses.

Customers

Semiconductor and systems companies.

Named by the company

What the filings disclose

Suppliers

Not a material disclosure in the 10-K.

Named by the company

13

Competitors & peersSite analysis

Competitors the 10-K names, and the peer group the company itself chose in its proxy statement. Nothing here is this site's own pick.

The 10-K describes EDA vendors, in-house customer tools, and simulation competitors without naming them.

Competitors named in the 10-K

Peer group the company chose

Peer group, from the proxy statement. Peers are companies the board considers comparable — for example when setting executive pay — not necessarily direct competitors.

Compensation peer group from the 2026 proxy statement.

Source: Proxy statement (2026)

Company names link to this site’s analysis where one exists; “site ↗” opens the company’s own website.

14

Six years of financialsFrom SEC data

Each chart's axis holds a single unit (never mixing dollars, %, and $/share). The table's per-period header links to the filing the numbers came from.

Revenue over time

Unit: $M

Source: each period's Form 10-K (SEC EDGAR). Latest: filed 2025-12-22

Profit over time (operating → net)

Unit: $M

  • Operating income
  • Pretax income
  • Net income

Source: each period's Form 10-K (SEC EDGAR). Latest: filed 2025-12-22

Margins over time

Unit: %

  • Operating margin
  • Net margin

formulaoperating income ÷ revenue × 100

termsOperating income · Revenue (net sales)

formulanet income attributable to the company ÷ revenue × 100

termsNet income (attributable to the company)

Cash flow over time

Unit: $M (below zero = cash went out)

  • Operating CF
  • Investing CF
  • Free CF

formulacash flow from operations − capital expenditures

termsFree cash flow (FCF) · Cash flow from operations (operating CF) · Capital expenditures (capex)

Source: each period's Form 10-K (SEC EDGAR). Latest: filed 2025-12-22

Financial stability & capital efficiency

Unit: %

  • Equity ratio
  • ROE

formulatotal equity ÷ total assets × 100 (as reported in the 10-K)

termsStockholders’ equity · Total assets

formulanet income ÷ average equity (beginning + ending, ÷2) × 100 (as reported in the 10-K)

termsNet income (attributable to the company) · Stockholders’ equity

Earnings per share (EPS) and dividend per share

Unit: $

  • EPS

Source: each period's Form 10-K (SEC EDGAR). Latest: filed 2025-12-22

Line itemFY202010-K on EDGAR ↗FY202110-K on EDGAR ↗FY202210-K on EDGAR ↗FY202310-K on EDGAR ↗FY202410-K on EDGAR ↗FY202510-K on EDGAR ↗
Income statement ($M)
Revenue3,6854,2045,0825,3186,1277,054
Operating income6207351,1491,2731,356915
Pretax income6388061,1031,3051,5141,393
Net income (attributable)6647589851,2302,2631,332
Revenue growthcalc(this year’s revenue − last year’s revenue) ÷ last year’s revenue × 100—14.1%20.9%4.7%15.2%15.1%
Operating margincalcoperating income ÷ revenue × 10016.8%17.5%22.6%23.9%22.1%13.0%
Net margincalcnet income attributable to the company ÷ revenue × 10018.0%18.0%19.4%23.1%36.9%18.9%
Balance sheet ($M)
Total assets8,0308,7529,41810,33313,07448,224
Total equity4,9125,2995,5216,1538,99328,328
Interest-bearing debtSum of short- and long-term borrowings, notes/bonds payable1012521181613,485
Equity ratio61.1%60.5%58.6%59.5%68.8%58.7%
ROE13.5%14.8%18.2%21.1%29.9%7.1%
Cash flow ($M)
Operating CF9911,4931,7391,7031,4071,519
Investing CF-360-549-573-4821,223-15,881
Financing CF-141-749-1,116-1,197-18113,356
Free cash flowcalccash flow from operations − capital expenditures8371,3991,6021,5141,2681,349
Cash and equivalents1,2361,4331,4181,4343,8972,888
Per share & other
EPS ($)4.274.816.297.9214.518.04
BVPS ($)32.1534.5936.2040.4358.34152.30
P/E (x)50.169.346.559.335.456.5
EV/EBITDA (x)calc(market cap + interest-bearing debt − cash and equivalents) ÷ (operating income + depreciation & amortization)38.052.831.446.045.660.3
P/B (x)calcfiscal year-end closing price ÷ book value per share6.659.638.0811.618.802.98

P/B and EV/EBITDA use each period’s period-end (fiscal year-end) figures, not the current share price. Figures without a "calc" tag are as reported in the Form 10-K (the consolidated financial statements and, for older years, earlier 10-Ks), pulled automatically from SEC EDGAR. Where a later filing restated a prior period, the restated figure is used.

Last 8 quarters

Three-month figures from 10-Q filings. Change is versus the same quarter a year earlier. Newest quarter on top.

Quarter endedRevenueOperating incomeNet incomeDiluted EPS
2026-07-31$2.48B+42.4%$357M+116.3%$546M+125.1%$2.84
2026-04-30$2.28B+41.9%$120M-68.0%$17M-95.0%$0.09
2026-01-31$2.41B+65.5%$203M-19.4%$65M-78.0%$0.34
2025-10-31 †$2.25B+37.8%$121M-60.9%$449M-59.7%—
2025-07-31$1.74B$165M$243M$1.50
2025-04-30$1.6B$376M$345M$2.21
2025-01-31$1.46B$252M$296M$1.89
2024-10-31 †$1.64B$311M$1.11B—

† Fourth quarter = the 10-K’s annual figure minus the first three quarters; quarterly EPS isn’t derived this way because share counts change during the year.

15

Is ROIC above WACC?From SEC data

ROIC (the return on money invested in the business) above WACC (the cost of raising that money) means the company is creating value. WACC is an estimate, so its assumptions can be adjusted below.

ROIC (FY2025)

3.4%

formulaoperating income × (1 − tax rate) ÷ invested capital × 100 *invested capital = interest-bearing debt + total equity (average of beginning/ending)

e.g.$915M × (1 − 6%) ÷ $25,410M × 100 = 3.4%

termsOperating income · Effective tax rate · Invested capital · Interest-bearing debt · Total equity

WACC (this site’s estimate)

11.15%

formulacost of equity × equity weight + cost of debt × (1 − tax rate) × debt weight

e.g.Equity weight: $84.41B ÷ ($84.41B + $13.48B) = 86.2%

e.g.Debt weight: $13.48B ÷ ($84.41B + $13.48B) = 13.8%

e.g.WACC: 12.4% × 86.2% + 3.3% × (1 − 6%) × 13.8% = 11.15%

termsCost of equity · Equity weight (E/(D+E)) · Cost of debt · (1 − tax rate) · Debt weight (D/(D+E)) · Market capitalization

ROIC − WACC

-7.8pt▼caution

Falling short of the cost of capital (ROIC > WACC in only 5 of 6 years)

formulaROIC − WACC (positive means the business earns more than its cost of capital)

termsROIC · WACC

How firm is this? With the equity risk premium ±1 point and beta ±0.2, WACC runs 9.2%–13.4% and ROIC − WACC runs −10.1 to −5.8 points. The sign holds across this range. This describes the latest year and does not predict future value creation.

WACC 11.15% is this site’s estimate under the assumptions below (not a figure the company has published)

Risk-free rate
4.95% (10-year Treasury, 2026-11-03)
β
1.36 (price-derived adjusted beta)
Equity risk premium
5.5%
Cost of equity
12.43%
Cost of debt
3.31%
Tax rate
6% (effective rate, FY2023–FY2025)
Capital structure (equity : debt)
86% : 14%
→ Change assumptions and recalculate

ROIC over time, vs. WACC

Unit: % — bars = each period's ROIC, horizontal line = latest WACC. Bars above the line are green, below are red

  • ROIC (above WACC)
  • ROIC (below WACC)
  • WACC 11.15%

formulaoperating income × (1 − tax rate) ÷ invested capital × 100 *invested capital = interest-bearing debt + total equity (average of beginning/ending)

termsOperating income · Effective tax rate · Invested capital · Interest-bearing debt · Total equity

formulacost of equity × equity weight + cost of debt × (1 − tax rate) × debt weight

termsCost of equity · Equity weight (E/(D+E)) · Cost of debt · (1 − tax rate) · Debt weight (D/(D+E)) · Market capitalization

Try different WACC assumptions

β and the equity risk premium are estimates with a real range of plausible values — move the sliders to check whether ROIC > WACC still holds. The risk-free rate starts at the 10-year Treasury yield on 2026-11-03 (U.S. Treasury).

Initial β: 1.36 (price-derived adjusted beta. Raw β 1.54, R² 0.24, 130 weeks)

formula0.67 × β + 0.33 (β = the slope of weekly stock returns regressed on weekly market returns)

e.g.0.67 × 1.541 + 0.33 = 1.362

termsβ (beta)

Period 2024-05-10–2026-11-04, using S&P 500 ETF (SPY) as the market proxy. Source: Yahoo Finance price history.

Cost of equity12.43%

formularisk-free rate + β × equity risk premium

e.g.5.0% + 1.36 × 5.5% = 12.4%

termsCAPM · Risk-free rate · β (beta) · Equity risk premium (market risk premium)

Market value of equity$84.41B

formulafiscal year-end closing price × shares outstanding (= market cap)

termsMarket capitalization · Market value of equity

Interest-bearing debt$13.48B
Cost of debt3.31%

formulainterest expense ÷ interest-bearing debt × 100 (clamped to 0–10%; falls back to the risk-free rate if there’s no debt)

termsInterest-bearing debt · Risk-free rate

Capital structure (equity weight : debt weight)86% : 14%

16

What the price implies (DCF)From SEC data

A company's value can be written as its free cash flow divided by (cost of capital − perpetual growth). Working that backwards from the market's valuation shows how much growth the share price assumed — compared here with the company's actual past growth.

Growth the price implies (price on 2026-11-04)

9.8%

Perpetual FCF growth: g = r − FCF ÷ EV = 11.1% − 1.4%

Past FCF growth (FY2020–FY2025)

+10.0%

Compound annual rate, 5 years

Past revenue growth (FY2020–FY2025)

+13.9%

Compound annual rate, 5 years

Inputs (FY2025): free cash flow $1.35B (operating CF − capex); enterprise value $97.02B = market cap $86.5B (latest close, 2026-11-04) + debt $13.48B − cash and short-term investments $2.96B; r = WACC of 11.1% using this page’s default assumptions (β 1.36, risk-free 5.0%, market premium 5.5%).

Three WACC scenarios

The same calculation under cautious, base and optimistic cost-of-capital assumptions (risk-free rate fixed at the 10-year Treasury yield). Pick one to load it into the sliders below.

Try your own assumptions

V = FCF ÷ (r − g). It starts at the implied growth rate, where the theoretical value equals today’s enterprise value.

Theoretical enterprise value

$103.78B

FCF $1.35B ÷ (11.1% − 9.8%)

Theoretical ÷ actual enterprise value

1.07x

Above 1x: these assumptions value the business above the market did

How sensitive the answer is

Theoretical ÷ actual enterprise value for each combination of r and g.

g \ r9.1%10.1%11.1%12.1%13.1%
0%0.15x0.14x0.13x0.11x0.11x
2%0.20x0.17x0.15x0.14x0.13x
4%0.27x0.23x0.20x0.17x0.15x
6%0.45x0.34x0.27x0.23x0.20x
8%1.26x0.66x0.45x0.34x0.27x

A simplified model for seeing what the market price assumes, not a forecast or a target price. It treats free cash flow as growing at one constant rate forever; the result swings widely with small changes in r and g, and is undefined when g reaches r. Free cash flow here is operating cash flow minus capex, which is after interest — a full DCF of enterprise value would use cash flow before interest. Market cap uses the latest close (2026-11-04) × shares at fiscal year-end; free cash flow and WACC inputs are from the latest fiscal year.

17

Earnings qualityFrom SEC dataShow

The same reported profit can mean different things depending on whether it's backed by cash, driven by the core business, or the result of a one-off item. Four checks below.

  • ✓

    Operating CF ÷ net income: averages 1.40x

    Profit is backed by cash coming in.

  • ✓

    Accrual ratio (latest): -0.6%

    A small share of profit rests on accounting estimates.

  • !

    Core-earnings share (operating income ÷ pretax income): 66%

    Non-operating items (interest income, equity-method gains, other income/expense) are having a bigger effect.

  • ✓

    Days sales outstanding: 77 → 63 days

    No major slowdown in collecting on sales.

Operating CF vs. net income

Unit: $M — operating CF above net income means profit is backed by cash

  • Operating CF
  • Net income

formulacash flow from operations ÷ net income attributable to the company

termsCash flow from operations (operating CF) · Net income (attributable to the company)

formula(net income − operating CF) ÷ average total assets × 100

termsNet income (attributable to the company) · Cash flow from operations (operating CF) · Total assets

Source: each period's Form 10-K (SEC EDGAR). Latest: filed 2025-12-22

Profit bridge (FY2025)

Unit: $M — what moved profit from operating income to net income

  • Profit (each stage)
  • Pushed profit up
  • Pushed profit down

formulaoperating income ÷ income before income taxes × 100

termsOperating income · Income before income taxes (pretax income)

Source: each period's Form 10-K (SEC EDGAR). Latest: filed 2025-12-22

Receivables & inventory days

Unit: days — days grow when receivables or inventory build up faster than sales

  • Days sales outstanding
  • Days inventory outstanding

formulaaverage receivables (opening + closing ÷ 2) ÷ revenue × 365

termsAccounts receivable · Revenue (net sales)

formulaaverage inventory (opening + closing ÷ 2) ÷ cost of revenue × 365

termsInventory · Cost of revenue (COGS)

Worked examples (latest period)

formulacash flow from operations ÷ net income attributable to the company

e.g.$1,519M ÷ $1,332M = 1.14x

termsCash flow from operations (operating CF) · Net income (attributable to the company)

formulaoperating income ÷ income before income taxes × 100

e.g.$915M ÷ $1,393M × 100 = 66%

termsOperating income · Income before income taxes (pretax income)

formulaaverage receivables (opening + closing ÷ 2) ÷ revenue × 365

e.g.($934M + $1,505M) ÷ 2 ÷ $7,054M × 365 = 63 days

termsAccounts receivable · Revenue (net sales)

formulaaverage inventory (opening + closing ÷ 2) ÷ cost of revenue × 365

e.g.($362M + $365M) ÷ 2 ÷ $1,624M × 365 = 82 days

termsInventory · Cost of revenue (COGS)

18

Who holds the sharesFrom SEC dataShow

How much of the stock large institutional investors report owning on SEC Form 13F, how much the directors and executive officers hold (and how much of the vote they control), and roughly how much is left for individual investors. Shown next to beta so the holder mix can be read alongside how much the stock swings.

Institutions, insiders and everyone else, 13F holdings as of 2026-06-30

“Everyone else” is what remains after shares reported on Form 13F and shares held by directors and executive officers: mostly individual investors, plus non-insider families or foundations and smaller or foreign institutions. The figures have different dates and 13F reports count some shares twice — read it as an approximate split.

Held by 13F filers
93.6%
Directors & officers (shares)
<1%
Everyone else (est.)
6.4%

individuals and other non-13F holders

Directors & officers (voting power)
<1%

no separate voting figure; shown as shares

Institutional-ownership rank
141 of 416

1 = most institutional; 34% of covered companies have more

Beta (adjusted)
1.36

above 1 = swings more than the market

  • 179.2M shares reported by 1,446 13F filers ÷ 191.5M shares outstanding on 2026-05-22. Option positions are excluded.
  • Directors and executive officers as a group, from the proxy statement’s beneficial-ownership table; includes shares they can acquire within 60 days.
  • A large “everyone else” share can still reflect a family, trust or foundation stake held outside the board; check the proxy statement’s 5% holders.

Sources: SEC Form 13F data set (holdings as of 2026-06-30) · Form DEF 14A filed 2026-02-19 (beneficial ownership table) · Form 10-Q cover page (shares outstanding as of 2026-05-22)

19

Strengths & weaknessesSite analysis

Strengths

  1. 1. Revenue growth

    Revenue rose from $3,685M (FY2020) to $7,054M (FY2025).

    Evidence: Form 10-K (FY2025, year ended 2025-10-31)

  2. 2. Stated leadership

    Calls itself a global leader in EDA and, after Ansys, in engineering simulation and analysis software.

    Evidence: Form 10-K (FY2025, year ended 2025-10-31)

  3. 3. Nine-month growth

    First nine months of FY2026 revenue rose 49%.

    Evidence: Form 10-Q (quarter ended 2026-07-31)

Weaknesses

  1. 1. Merger debt

    Debt rose from $16M to $13,485M in FY2025.

    Evidence: Form 10-K (FY2025, year ended 2025-10-31)

  2. 2. Lower profit

    Operating income fell to $915M in FY2025 from $1,356M.

    Evidence: Form 10-K (FY2025, year ended 2025-10-31)

  3. 3. Design IP decline

    Design IP revenue fell 8% in FY2025.

    Evidence: Form 10-K (FY2025, year ended 2025-10-31)

20

What draws investors to itSite analysis

Why the stock can look attractive to investors — each point paired with what has to hold for it to stay true, and the opposing view. This is this site's analysis, not a recommendation to buy or sell.

P/E (FY2025)

56.5x

Price at fiscal year-end ÷ diluted EPS

Dividend yield (FY2025)

—

Dividends per share ÷ fiscal year-end price

Payout ratio (FY2025)

—

Dividends per share ÷ diluted EPS

FCF yield (FY2025)

1.6%

(Operating CF − capex) ÷ market cap

  1. 1. Silicon to systems

    Combines EDA, IP and simulation after Ansys.

    What has to hold
    Integration delivers.
    The other side
    Debt and integration risk.

    Evidence: Form 10-K (FY2025, year ended 2025-10-31)

  2. 2. Recurring licensing

    Time-based products were 49% of FY2025 revenue.

    What has to hold
    Renewals continue.
    The other side
    Export limits on China.

    Evidence: Form 10-K (FY2025, year ended 2025-10-31)

Pays no dividend.

21

ResilienceSite analysisShow

How well the company could absorb a bad year: its financial buffer, how its revenue and profit held up in the worst year on record, and what the 10-K says about the business's exposure to shocks. Figures and filing statements only — no overall rating.

1. Financial buffer (FY2025)

Cash & short-term investments ÷ debt due within a year

100x+

$2.96B vs. $22M

Interest coverage (operating income ÷ interest expense)

2.0x

$915M vs. $447M

Free cash flow ÷ dividends paid

—

2. Worst year in the record, and the recovery

FigureWorst year-over-year changeBack to the prior level?
RevenueNo decline in the record—
Operating income-32.5% in FY2025 ($1.36B → $915M)Not yet, as of FY2025

Covers only the 6 fiscal years on record (FY2020–FY2025), which may not include a full recession — the worst year here isn’t necessarily how the company would fare in a severe downturn.

3. Business resilience (from the 10-K)

  • Profitable through 2020

    Net income of $664M in FY2020.

    Source: Form 10-K (FY2025, year ended 2025-10-31)

23

Risks (including geopolitical)Site analysis

Starting from the 10-K's Risk Factors section, organized by category — geopolitical, currency, raw materials, regulatory, disaster, and more — with impact and likelihood assessed by this site.

Risk map

Vertical = impact on results, horizontal = likelihood. Upper right = most severe. Numbers match the list below (placement is this site’s own assessment).

Impact
High
2
1
Med
3
45
Low
LowMedHigh

Likelihood →

"Company disclosure" vs. "this site’s assessment"

The description and mitigation for each risk are this site’s summary of the 10-K’s "Risk Factors" section. Impact and likelihood are this site’s own assessment, not the company’s — where the company discloses its own likelihood assessment, that is noted in the summary.

Impact is judged from how large the affected business is relative to total revenue/profit, and from the risk’s track record of moving results in the past. Likelihood is judged from the filing’s wording and the current business environment (already occurring, or recurring). See the rating criteria.

  1. 1Geopolitics & supply chain

    China export controls

    Company disclosure (summarized from the 10-K)
    BIS restrictions imposed in Q3 2025 and later rescinded hurt China business, and BIS subpoenas concern certain Chinese entities.
    Company’s stated mitigation
    Not stated in the filings.
    This site’s assessment
    Impact High / Likelihood High
  2. 2M&A & integration

    Ansys integration

    Company disclosure (summarized from the 10-K)
    Ansys acquisition, completed July 17, 2025.
    Company’s stated mitigation
    Not stated in the filings.
    This site’s assessment
    Impact High / Likelihood Med
  3. 3Funding & liquidity

    Debt load

    Company disclosure (summarized from the 10-K)
    About $13.5B of debt after the merger.
    Company’s stated mitigation
    Not stated in the filings.
    This site’s assessment
    Impact Med / Likelihood Med
  4. 4Competition & technology shift

    EDA competition

    Company disclosure (summarized from the 10-K)
    Competes with EDA vendors and customers’ in-house tools.
    Company’s stated mitigation
    Not stated in the filings.
    This site’s assessment
    Impact Med / Likelihood High
  5. 5Law & regulation

    Securities litigation

    Company disclosure (summarized from the 10-K)
    Securities class action and derivative suits filed in 2025–2026.
    Company’s stated mitigation
    Not stated in the filings.
    This site’s assessment
    Impact Med / Likelihood High

24

What changed in the risk factorsFrom SEC data

Paragraphs in the latest 10-K's Risk Factors that have little overlap with the year before, and paragraphs that were dropped.

New or substantially reworded (7)

  • decrease and our business, operating results and financial condition could be adversely affected. Read more

    For example, while we have seen continued strength in the artificial intelligence and high-performance computing sectors, certain industries such as industrial, automotive and consumer electronics have recovered more slowly from recent macroeconomic uncertainty, which have affected our business and operating results.

  • Our Ansys business distributes its products through a global network of independent channel partners. Read more

    Difficulties in ongoing relationships with channel partners, such as failure to meet performance criteria, differences in handling customer relationships or the loss of a major channel partner, could adversely affect the performance of our Ansys business. Channel partners may also result in additional compliance burdens for us and any failure by them to comply with various U.S. and foreign laws could subject us to, among other things, investigations, fines, enforcement actions, civil or criminal penalties or injunctions.

  • We have incurred a substantial amount of debt in connection with the Ansys Merger, including the Senior Notes and the $4.3 billion term loan. Read more

    Accordingly, as of October 31, 2025, we had approximately $13.5 billion of total debt.

  • We or our directors or officers are subject to litigation proceedings, which are expensive, could divert management attention and harm our business.

  • For example, we are currently named as a defendant in recently filed securities class action complaints. Read more

    The stock market in general, and Nasdaq and technological companies in particular, have experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of companies. The market price of our common stock is or may be volatile. In the past, companies that have experienced volatility in the market price of their stock have been subject to securities class action litigation.

  • In addition, certain of our directors and officers may be involved in ongoing securities or other lawsuits, including in the context of their roles with other public companies, and our directors or officers may in the future become

  • involved in such litigation. Securities litigation, including the cost to defend against, and any potential adverse outcome resulting from any such proceeding, can be expensive, time-consuming, damage our reputation and divert our management’s and board of directors’ attention from other business concerns, which could seriously harm our business. As noted above, on October 31, 2025 and November 25, 2025, respectively, two shareholder class action complaints were filed in the United States District Court for the Northern District of California against Synopsys and certain of our current directors and officers. Both complaints allege that certain material misstatements or omissions related to the performance of our Design IP segment were made in violation of federal securities laws. There is no guarantee that we will be successful in our efforts to defend against these complaints. Further…

No longer in the text (4)

  • Our business is subject to numerous risks and uncertainties. These risks include, but are not limited to, the following:

  • • As a result of the Ansys Merger, we anticipate that the scope and size of our operations and business will substantially change and will result in certain incremental risks to us, including increased competition. Read more

    We may not realize the full expected benefits of the Ansys Merger.

  • • Changes in demand for our products due to customers reducing their expenditures, which may be a result of customer cost-cutting measures or insolvency or bankruptcy, sustained global inflationary pressures and elevated interest rates or other reasons;

  • • General economic and political conditions that affect the semiconductor and electronics industries, such as disruptions to international trade relationships, including tariffs, changes in Export Regulations, or other trade barriers affecting our or our suppliers’ products; and

18 more paragraphs differ; the filings below have the full text.

Matched automatically, quoted as filed, and may include rewording of an existing risk. Compares Item 1A of the 10-K filed Dec 22, 2025 ↗ with the 10-K filed Dec 19, 2024 ↗.

25

What to watch going forwardSite analysis

  • Consolidated securities complaint.
  • China revenue and export rules.
  • Integration savings from the restructuring.

26

Source documentsShow

This page's financial figures come from the Form 10-Ks listed below. Check the original filings for full detail.

Last updated

Analysis last edited: November 6, 2026 · Financial data fetched: November 4, 2026 15:22 (SEC EDGAR) · Source 10-K filed: December 22, 2025

Built on10-K FY2025 · filed 2025-12-22Proxy statement (2026)

Next update expectedAfter FY2026’s 10-K is filed (roughly 60–90 days after fiscal year end (sooner for larger filers)), financials and analysis will be refreshed.

This page is this site’s own analysis based on public information, and does not represent Synopsys’s views. It is not a recommendation to buy or sell any security, and this site does not guarantee the accuracy of any figure or statement here. Always verify against the original source documents before making an investment decision.